Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devico

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Current HIV Research|September 11, 2015
Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and TreatmentOlga S Latinovic, Jian Zhang, Yutaka Tagaya, et al.
AIDS Research and Human Retroviruses|March 1, 1990
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1V S Kalyanaraman, V Rodriguez, F Veronese, et al.
Molecular Pharmacology|October 1, 1988
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitroZ Hao, D A Cooney, N R Hartman, et al.
Journal of Virology|October 14, 2011
Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteinsGeorge K Lewis, Timothy R Fouts, Sani Ibrahim, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic AssaysZahra Rikhtegaran Tehrani, Saman Saadat, Ebtehal Saleh, et al.
Plos One|November 2, 2020
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assaysZahra Rikhtegaran Tehrani, Saman Saadat, Ebtehal Saleh, et al.
Science (New York, N.Y.)|March 13, 1992
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin MB C Nair, A L DeVico, S Nakamura, et al.
Annals of Internal Medicine|March 1, 1985
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in BostonJ E Groopman, K H Mayer, M G Sarngadharan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitroH Mitsuya, R F Jarrett, M Matsukura, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infectionF Cocchi, A L DeVico, R Yarchoan, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Current HIV Research|September 11, 2015
Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and TreatmentOlga S Latinovic, Jian Zhang, Yutaka Tagaya, et al.
AIDS Research and Human Retroviruses|March 1, 1990
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1V S Kalyanaraman, V Rodriguez, F Veronese, et al.
Molecular Pharmacology|October 1, 1988
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitroZ Hao, D A Cooney, N R Hartman, et al.
Journal of Virology|October 14, 2011
Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteinsGeorge K Lewis, Timothy R Fouts, Sani Ibrahim, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic AssaysZahra Rikhtegaran Tehrani, Saman Saadat, Ebtehal Saleh, et al.
Plos One|November 2, 2020
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assaysZahra Rikhtegaran Tehrani, Saman Saadat, Ebtehal Saleh, et al.
Science (New York, N.Y.)|March 13, 1992
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin MB C Nair, A L DeVico, S Nakamura, et al.
Annals of Internal Medicine|March 1, 1985
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in BostonJ E Groopman, K H Mayer, M G Sarngadharan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitroH Mitsuya, R F Jarrett, M Matsukura, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infectionF Cocchi, A L DeVico, R Yarchoan, et al.
Pageof 13